Skip to main content

Centiva Capital, LP

Position in BSX — Boston Scientific Corp

CIK 1692507 New York, NY

Position in BSX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,274,750
+$804,415 QoQ
Shares Held
36,251
+164.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2024
CallValue
$2,739,600
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Centiva Capital, LP holds $19,656,429 across 27 Medical Devices names. BSX ranks #3 (11.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BSX
Boston Scientific Corp
This page
36,251 $2,274,750

All Filings in BSX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,274,750 36,251
2025-06-30 $1,470,335 13,689
2025-03-31 $1,617,308 16,032
2024-12-31 $728,940 8,161
2024-09-30 $1,257,335 15,004
2024-06-30 $1,504,775 19,540
2024-03-31 $2,739,600 40,000
2023-12-31 $333,737 5,773
2023-12-31 $3,468,600 60,000
2023-12-31 $196,554 3,400
2023-09-30 $108,715 2,059
2023-09-30 $707,520 13,400
2023-09-30 $1,056,000 20,000
2023-06-30 $1,665,160 30,785
2023-06-30 $183,906 3,400
2023-06-30 $1,925,604 35,600
2023-03-31 $133,630 2,671
2023-03-31 $1,781,068 35,600
2022-12-31 $865,711 18,710
2022-06-30 $394,502 10,585
2021-06-30 $1,667,597 38,999